Short‐term chemosensory distortions and phantoms in COVID‐19
Open Access
- 1 February 2021
- journal article
- research article
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 6 (2), 172-176
- https://doi.org/10.1002/lio2.532
Abstract
Objective To identify differentiation features of chemosensory dysfunction in COVID‐19 infection and their primary drivers. Study Design Cross‐sectional cohort comparison. Methods A national anonymous survey was used to query participants regarding nasal symptoms and chemosensory dysfunction including sensitivity levels, and presence or absence of distortions and phantoms within the 6‐week time window surrounding their COVID‐19 testing and survey completion. Results Three‐hundred and sixty‐four respondents who reported COVID‐19 positive (COVID+; n = 176) or COVID‐19 negative (COVID−; n = 188) test results completed the survey. The COVID+ cohort had higher occurrence rates for: (a) chemosensory sensitivity impairments (67.0% vs 30.3%; P < .01), where the rate of complete loss of smell (anosmia) or taste (ageusia) was higher (35.8% vs 4.8%; P < .01), and (b) chemosensory distortions (39.8% vs 19.1%; P < .01), where the rate of anosmia or ageusia with distortions was also higher in the COVID+ cohort (19.9% vs 2.7%; P < .01). Occurrence rates in the two cohorts were similar for chemosensory phantoms (COVID+ 17.0%, COVID− 18.6%; P = .70) and nasal discharge or stuffiness in the presence of sensitivity impairment (COVID+ 63.6%, COVID− 52.6%; P = .17). Conclusion Chemosensory dysfunction in COVID‐19 is associated with higher rates of smell or taste sensitivity impairments and distortions. Higher rates of anosmia and ageusia drive these key findings. Chemosensory phantoms and nasal symptoms in the presence of sensitivity impairment occur at rates that should demand clinical attention, but they do not appear to be specific to COVID‐19 positivity. Level of Evidence 2b.Keywords
This publication has 27 references indexed in Scilit:
- Postinfectious olfactory loss: A retrospective study on 791 patientsThe Laryngoscope, 2018
- New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunctionReviews in Endocrine and Metabolic Disorders, 2016
- Evaluating the clinical usefulness of structured questions in parosmia assessmentThe Laryngoscope, 2010
- Identification of Viruses in Patients With Postviral Olfactory DysfunctionThe Laryngoscope, 2007
- Characteristics of Olfactory Disorders in Relation to Major Causes of Olfactory LossJAMA Otolaryngology–Head & Neck Surgery, 2002
- The Diagnosis of a Conductive Olfactory LossThe Laryngoscope, 2001
- Olfactory Threshold and Nasal Mucosal Changes in Experimentally Induced Common ColdActa Oto-Laryngologica, 1995
- Smell and Taste Disorders, A Study of 750 Patients From the University of Pennsylvania Smell and Taste CenterJAMA Otolaryngology–Head & Neck Surgery, 1991
- Changes in Human Nasal Mucosa during Experimental Coronavirus Common ColdsActa Oto-Laryngologica, 1989
- Evaluation of olfactory dysfunction in the connecticut chemosensory clinical research centerThe Laryngoscope, 1988